Evans John M. — SEC insider filings
SEC reporting owner CIK 1786304. 33 insider filings on record with FilingPulse; latest filed 2026-10-16.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2020-08-17 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 105 legs across 24 filings — 956,758 shares, $39,818,346 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 60,000 shares @ $33.86 ($2,031,402) in Beam Therapeutics Inc., filed 2024-04-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | CEO, Director | 32 | — | 105 legs · 956,758 sh · $39,818,346 | 68 |
| Verve Therapeutics, Inc. (VERV) | Director | 1 | — | — | 1 |
Insider filings — Evans John M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-16 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $1.03 · Sale (S): 25,000 @ $23.57 · Option exercise (M): 25,000 @ $1.03 · Sale (S): 25,000 @ $23.98 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 18,663 @ $0.67 · Option exercise (M): 6,337 @ $1.03 · Sale (S): 13,421 @ $35.13 · Sale (S): 11,579 @ $35.91 · Option exercise (M): 25,000 @ $1.03 · Sale (S): 23,100 @ $34.26 · +4 more | EDGAR |
| 2026-04-06 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 30,078 @ $24.58 | EDGAR |
| 2026-04-01 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.37 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $22.76 · Grant/award (A): 90,000 @ $0 · Option exercise (M): 25,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 19,336 @ $0.67 · Option exercise (M): 5,664 @ $0.67 · Sale (S): 16,333 @ $29.19 · Sale (S): 8,667 @ $29.74 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 22,094 @ $28.27 · +5 more | EDGAR |
| 2025-10-03 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.51 · Option exercise (M): 25,000 @ $0.67 · Sale (S): 25,000 @ $24.63 · Option exercise (M): 25,000 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 30,663 @ $18.35 | EDGAR |
| 2025-04-02 | 4/A | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 30,000 @ $0.67 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 77,500 @ $0 | EDGAR |
| 2025-02-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 29,800 @ $26.75 · Sale (S): 200 @ $27.28 · Grant/award (A): 155,000 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $24.60 | EDGAR |
| 2024-06-28 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $24.50 | EDGAR |
| 2024-04-03 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 18,102 @ $32.13 · Grant/award (A): 99,336 (derivative) @ $0 · Grant/award (A): 53,965 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $33.86 · Grant/award (A): 77,500 @ $0 | EDGAR |
| 2024-02-02 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 60,000 @ $25.33 · Grant/award (A): 155,000 (derivative) @ $24.40 | EDGAR |
| 2023-04-05 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 5,161 @ $30.31 · Sale (S): 6,493 @ $29.09 | EDGAR |
| 2023-03-31 | 4 | Beam Therapeutics Inc. (BEAM) | Code (L): 225 @ $0 · Grant/award (A): 56,250 @ $0 · Option exercise (M): 13,850 @ $7.22 · Grant/award (A): 112,500 (derivative) @ $0 · Option exercise (M): 13,850 (derivative) @ $0 | EDGAR |
| 2022-11-02 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 7,567 @ $44.92 · Sale (S): 7,768 @ $46.19 · Sale (S): 11,756 @ $46.88 · Sale (S): 2,909 @ $47.89 · Sale (S): 5,008 @ $44.93 · Sale (S): 4,569 @ $46.19 · +2 more | EDGAR |
| 2022-07-29 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 10,181 @ $64.87 · Sale (S): 15,236 @ $65.82 · Sale (S): 1,562 @ $66.74 · Sale (S): 2,848 @ $67.80 · Sale (S): 173 @ $68.49 · Sale (S): 6,953 @ $64.88 · +3 more | EDGAR |
| 2022-06-13 | 4 | Verve Therapeutics, Inc. (VERV) | Grant/award (A): 15,500 (derivative) @ $0 | EDGAR |
| 2022-05-02 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 12,246 @ $7.22 · Option exercise (M): 47,204 @ $1.03 · Sale (S): 3,900 @ $36.59 · Sale (S): 13,655 @ $37.48 · Sale (S): 6,842 @ $38.32 · Sale (S): 4,503 @ $39.49 · +8 more | EDGAR |
| 2022-04-04 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 56,250 @ $0 · Sale (S): 6,261 @ $59.11 | EDGAR |
| 2022-02-02 | 4/A | Beam Therapeutics Inc. (BEAM) | Gift (G): 12,000 @ $0 · Sale (S): 801 @ $63.79 · Sale (S): 2,172 @ $64.47 · Sale (S): 3,177 @ $65.49 · Sale (S): 6,337 @ $66.55 · Sale (S): 13,535 @ $67.44 · +10 more | EDGAR |
| 2021-10-08 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 27,700 @ $1.03 · Sale (S): 3,149 @ $82.72 · Sale (S): 13,406 @ $83.47 · Sale (S): 10,444 @ $84.45 · Sale (S): 701 @ $85.19 · Sale (S): 2,171 @ $82.71 · +4 more | EDGAR |
| 2021-09-21 | 4/A | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 99,336 (derivative) @ $0 · Grant/award (A): 53,964 (derivative) @ $0 | EDGAR |
| 2021-08-20 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 400 @ $96.38 · Sale (S): 1,000 @ $97.50 · Sale (S): 3,140 @ $98.74 · Sale (S): 9,704 @ $99.53 · Sale (S): 5,456 @ $100.35 · Sale (S): 300 @ $101 · +2 more | EDGAR |
| 2021-07-08 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 25,000 @ $1.03 · Sale (S): 645 @ $100.69 · Sale (S): 2,300 @ $101.27 · Sale (S): 100 @ $102 · Sale (S): 2,864 @ $103.52 · Sale (S): 1,336 @ $104.40 · +9 more | EDGAR |
| 2021-06-30 | 4 | Beam Therapeutics Inc. (BEAM) | Code (L): 32 @ $0 · Code (L): 32 @ $0 · Other (J): 32 @ $0 | EDGAR |
| 2021-04-23 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 1,463 @ $67.90 · Sale (S): 5,079 @ $69.02 · Sale (S): 5,595 @ $70.23 · Sale (S): 9,869 @ $71.38 · Sale (S): 2,994 @ $71.79 · Option exercise (M): 6,000 @ $1.03 · +1 more | EDGAR |
| 2021-04-12 | 4 | Beam Therapeutics Inc. (BEAM) | Code (L): 33 @ $0 · Code (L): 32 @ $0 · Code (L): 32 @ $0 | EDGAR |
| 2021-04-02 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 69,375 @ $0 · Grant/award (A): 138,750 (derivative) @ $0 | EDGAR |
| 2021-01-04 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 1,366 @ $81.14 · Sale (S): 4,100 @ $82.33 · Sale (S): 4,925 @ $83.76 · Sale (S): 1,422 @ $85.35 · Sale (S): 7,196 @ $86.21 · Sale (S): 504 @ $86.79 · +2 more | EDGAR |
| 2020-08-17 | 4 | Beam Therapeutics Inc. (BEAM) | Option exercise (M): 115,000 @ $1.03 · Option exercise (M): 115,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs